Sunshine Guojian Pharmaceutical (688336.SH) announced that it has approved the "Proposal on Restricted Stock Incentive Plan until 2024"...
According to the announcement released by Sunshine Guojian Pharmaceutical (688336.SH) on the Zhitong Finance and Economics App, the company has approved the "Proposal on the Initial Grant of Restricted Stock to Incentive Objects under the Restricted Stock Incentive Plan until 2024" and the "Proposal on Adjusting the Grant Price of the Restricted Stock Incentive Plan until 2024". The first grant date is July 30, 2024, and 5,174,500 stocks of restricted stock will be granted to 92 incentive objects at the grant price of 11.95 yuan/share.